Bup-4


Indications and Reactions:

Role Indications Reactions
Secondary
Prostate Cancer 12.5%
Benign Prostatic Hyperplasia 10.7%
Product Used For Unknown Indication 9.8%
Diabetes Mellitus 7.1%
Pollakiuria 7.1%
Prostate Cancer Stage Iii 7.1%
Arthralgia 6.3%
Hypertension 6.3%
Depression 5.4%
Arterial Occlusive Disease 4.5%
Hyperlipidaemia 3.6%
Chronic Myeloid Leukaemia 2.7%
Constipation 2.7%
Osteoporosis 2.7%
Pain 2.7%
Anaemia Macrocytic 1.8%
Asthma 1.8%
Atrial Fibrillation 1.8%
Bronchopulmonary Aspergillosis 1.8%
Gastric Mucosal Lesion 1.8%
Platelet Count Decreased 10.8%
Blood Creatine Phosphokinase Increased 8.1%
Hepatic Function Abnormal 8.1%
Mental Disorder 8.1%
Death 5.4%
Interstitial Lung Disease 5.4%
Intestinal Obstruction 5.4%
Pneumonia 5.4%
Pneumonitis 5.4%
Pollakiuria 5.4%
Pyrexia 5.4%
Somnolence 5.4%
Cardiac Failure Acute 2.7%
Dizziness 2.7%
Haematuria 2.7%
Ileus 2.7%
Leukoencephalopathy 2.7%
Loss Of Consciousness 2.7%
Photophobia 2.7%
Renal Failure 2.7%
Concomitant
Hypertension 18.3%
Prophylaxis 9.0%
Rheumatoid Arthritis 7.4%
Product Used For Unknown Indication 6.7%
Benign Prostatic Hyperplasia 5.9%
Constipation 5.7%
Drug Use For Unknown Indication 5.2%
Pollakiuria 4.4%
Prostate Cancer 4.3%
Gastritis 4.1%
Insomnia 4.0%
Neurogenic Bladder 3.9%
Osteoporosis 3.4%
Diabetes Mellitus 3.3%
Dysuria 3.3%
Hypertonic Bladder 2.5%
Cancer Pain 2.2%
Cerebral Infarction 2.1%
Psoriasis 2.1%
Depression 2.0%
Interstitial Lung Disease 14.6%
Pneumonia 7.0%
Urinary Tract Infection 6.4%
Hepatic Function Abnormal 5.3%
Platelet Count Decreased 5.3%
Vomiting 5.3%
White Blood Cell Count Increased 5.3%
Palmar-plantar Erythrodysaesthesia Syndrome 4.7%
Pyrexia 4.7%
Renal Impairment 4.7%
Palpitations 4.1%
Renal Failure Acute 4.1%
Respiratory Arrest 4.1%
Hyponatraemia 3.5%
Liver Disorder 3.5%
Purpura 3.5%
Renal Failure 3.5%
Thrombocytopenia 3.5%
Tuberculosis 3.5%
Urinary Retention 3.5%

Drug Data